title: [Establishment of surgical blood ordering schedule and relative influential factors for tumor patients].
abstract: OBJECTIVE
  To design a blood ordering schedule and explore the influencing factors of blood utilizing and ordering for tumor surgical patients.
  
  
  METHODS
  For a total of 58 306 tumor surgical patients, 22 643 applications of blood ordering and 7430 person-times of blood utilization from October 2002 to May 2012 were retrospectively analyzed at Cancer Hospital of Chinese Academy of Medical Sciences. Their clinical profiles and test results were analyzed.
  
  
  RESULTS
  The operative transfusion rate was 32.81%. According to the operation position and the blood transfusion and preparation data, the surgical blood ordering schedule of tumor patients was established. Patient gender, hemoglobin, hematocrit, platelet, total protein and albumin level test results had significant effect on the transfusion of red blood cells (OR = 0.797, 9.614, 1.949, 0.437,0.444, 2.038, all P < 0.05). Patient gender, hemoglobin, hematocrit, activated partial thromboplastin time, prothrombin time, albumin and total protein level test results had significant effect on the transfusion of plasma (OR = 0.851, 1.367, 1.801, 1.652, 2.922, 2.224, 1.362, all P < 0.05) .
  
  
  CONCLUSIONS
  For surgical tumor patients, blood ordering should be based upon the test results of routine blood, blood coagulation and protein level test results to ensure that blood transfusion is both rational and safe.
authors.affiliation: Department of Blood Transfusion, Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
authors.forename: Xi-ying
authors.initials: XY
authors.lastname: Li
authors.affiliation: Department of Blood Transfusion, Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China. Email: zgh02xk@163.com.
authors.forename: Guo-hua
authors.initials: GH
authors.lastname: Zhao
authors.affiliation: Department of Blood Transfusion, Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
authors.forename: Min
authors.initials: M
authors.lastname: Liu
authors.affiliation: Department of Blood Transfusion, Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
authors.forename: Tao
authors.initials: T
authors.lastname: Peng
authors.affiliation: Department of Blood Transfusion, Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
authors.forename: Dong-yan
authors.initials: DY
authors.lastname: Zhou
authors.affiliation: Department of Blood Transfusion, Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
authors.forename: Jing-jing
authors.initials: JJ
authors.lastname: Yu
authors.affiliation: Department of Blood Transfusion, Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
authors.forename: Wei-qi
authors.initials: WQ
authors.lastname: Zhao
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001771:Blood Banks / Q000458:organization & administration; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000601:surgery*; D012189:Retrospective Studies; D055815:Young Adult